Originally Posted by
MAC
Yes, in fact they have gone one better, in offering what will be ultimately, by the end of next year, a total of four separate Cxbladder test products with four quite distinct markets.
Two products probably to be marketed to specialist urologists, and two products probably better marketed directly to GP's.
The advantage to Pacific Edge is that they can offer very high clinical test results with four separate products, rather than just a general single test which would cover all markets only adequately.
There's all the potential in the world,
Athough, we should not expect Pacific Edge to appoint a partner, if they are going too, until after the KP study is released and they announce the launch of Cxbladder(triage) in the US sometime soon.